OPKO Health, Inc.OPKNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank86
3Y CAGR+18.9%
5Y CAGR+10.5%
Year-over-Year Change
Research and development spending
3Y CAGR
+18.9%/yr
vs -14.1%/yr prior
5Y CAGR
+10.5%/yr
Recent acceleration
Acceleration
+33.0pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $124.08M | +17.9% |
| 2024 | $105.21M | +17.4% |
| 2023 | $89.59M | +21.3% |
| 2022 | $73.89M | -3.9% |
| 2021 | $76.85M | +2.0% |
| 2020 | $75.32M | -36.1% |
| 2019 | $117.87M | -13.1% |
| 2018 | $135.69M | +7.3% |
| 2017 | $126.44M | +11.0% |
| 2016 | $113.87M | - |